1. Catalog
  2. ORN Summer 2024 - Xylazine Wound Care Clinic and P ...
Image For Activity Cover
ORN Summer 2024 - Xylazine Wound Care Clinic and Protocol
Description:
People who use drugs across the United States are reporting a novel type of wound associated with the fentanyl-adulterant veterinary sedative, xylazine. While the mechanism behind wound formation has yet to be fully described, traditional wound science with a harm reduction approach can be effectively utilized to guide care for people who use drugs who develop wounds. This presentation leverages the experience of a low-barrier, nurse-led clinic in Kensington, Philadelphia, PA, which remains the epicenter of the xylazine epidemic, to describe evidence-informed practices for assessing and treating xylazine-associated wounds while responding to the real-world needs and challenges of a criminalized and socially alienated population. 

 

Learning objectives:
At the conclusion of this seminar, attendees should be able to:
  1. Describe basic concepts of the current xylazine epidemic.
  2. Explain health-related harms to people exposed to the unregulated drug supply, including illicit xylazine.
  3. Apply basic wound science to assess wounds and determine an evidence-informed wound care approach.
  4. Develop treatment plans that leverage harm reduction to meet the specific needs and challenges of people who use drugs.
Instructions and Claiming CME
What is ORN
Speaker:
Rachel McFadden, MPH, BSN, RN, CEN

Rachel McFadden, MPH, RN, CEN, is a nurse the Hospital of the University of Pennsylvania Emergency Department, and at Prevention Point Philadelphia's Wound Care Clinic. The foundation of her clinical philosophy and practice is harm reduction - a social justice movement as well as a practical approach to reducing the negative consequences of substance use. As a Bloomberg Fellow at the Johns Hopkins School of Public Health, her work centers on reducing stigma and strengthening healthcare's capacity to respond to the opioid/substance use crisis through the integration of harm reduction, while bridging medical services to community-based and public health efforts.
DISCLAIMER

ACCREDITATION:
This actvity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Osteopathic Association and The American Osteopathic Academy of Addiction Medicine (AOAAM). The American Osteopathic Association is accredited by the ACCME to provide continuing medical education for physicians.

CREDIT HOURS:
The American Osteopathic Association designates this other activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

DISCLOSURE AND CONFLICT OF INTEREST RESOLUTION:
All conflicts of interest of any individual(s) in a position to control the content of this CME activity will be identified and resolved prior to this educational activity being provided. Disclosure about provider and faculty relationships, or the lack thereof, will be provided to learners.

Funding:

Funding for this initiative was made possible (in part) by grant no. 1H79TI085588-02 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Summary
Availability: No future session
Expires on Aug 01, 2027
Cost: FREE
Credit Offered:
1 AMA PRA Category 1 Credit
1 AOA Category 1A Credit
Create Account
Recommended
Powered By